Sovaldi is a prescription medication used to treat chronic hepatitis C virus (HCV) infection in adults. It belongs to a class of drugs called nucleotide analog inhibitors, which work by blocking a specific enzyme the virus needs to replicate. Sovaldi is typically used as part of a combination therapy with other medications, such as ribavirin or interferon. It is taken orally as a tablet once a day for 12-24 weeks, depending on the specific genotype of the virus and the patient’s medical history. Sovaldi has been shown to be highly effective in curing HCV infection, with cure rates of up to 97% in some studies. However, it is also very expensive, with a cost of over $80,000 for a 12-week treatment course in the United States.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page